“ Building a Better Future:
ARMI's Commitment to Advancing Regenerative Medicine and Immunotherapy ”
Research and Development
Regenerative medicine, broadly defined, is the field of medicine dedicated to the regeneration of damaged or diseased organs and tissues using stem cells or other tissue sources. Immunotherapy is the use of drugs or other treatments to promote the body's natural ability to recognize and fight against cancer and other diseases. Recent regenerative medicine research has focused on developing safe, effective treatments to help restore or rebuild tissue, organs, and organ systems. Similarly, researchers are exploring the use of immune cells and engineered molecules to boost or "prime" the body's own defence mechanisms to fight off cancer and infectious diseases. Examples of immunotherapy research include developing new antibody-based drugs, vaccines, and other treatments to try and prevent or limit the progression of cancer and other diseases, as well as enhancing the body's natural ability to recognize and respond to pathogens. While there is tremendous potential for regenerative medicine and immunotherapy, many challenges remain, requiring further research and clinical trials before these treatments can be fully implemented.
Sep 5th - 6th 2024 @ Aloft Kuala Lumpur Sentral
2nd International Interventional Pain Update (IIPU) 2024
Upcoming Events and Workshops
Overview of Regenerative Medicine and Immunotherapy
Stem cells are important for both understanding and treating various diseases, particularly cancer. Immunotherapy is the use of the body's own immune system to fight disease. Stem cells offer immunotherapy potential, due to their ability to differentiate into other cell types, including immune cells such as T cells and B cells. Stem cell-derived immune cells can be used to treat cancer patients, as these cells can target and attack tumour cells. Additionally, stem cell-derived immune cells can be engineered to secrete molecules that can protect against cancer. Furthermore, stem cells can be used to investigate how the immune system is affected by certain drugs which allow the design of better immunotherapies.
About Us
Asia Pacific Regenerative Medicine and Immunotherapy (ARMI) is an independent, non-profit organization that aims to promote and expand Regenerative Medicine and Immunotherapy and their applications to improving human well-being.
Through educational programs that foster scientific exchange and collaboration. ARMI emphasizes high-calibre scientific meetings; dedication to education and outreach activities; focus on initiatives of major importance in the field, and commitment to collaborations with like-minded domestic & international organizations, government and regulatory agencies, associations, and patient advocacy groups, ARMI brings together all aspects of the regenerative medicine and immunotherapy.
Collaboration and Partnership
Upcoming Events and Workshops
ARMI's Inaugural Annual Meeting
The inaugural Annual Meeting of the Asia Pacific Regenerative Medicine and Immunotherapy Association (ARMI) marked a significant milestone in the field of regenerative medicine and immunotherapy. Held on October 5th, 2023, at the esteemed Doubletree by Hilton, Kuala Lumpur, the event gathered distinguished speakers and delegates from various sectors, including notable representatives from the United States, Finland, and Singapore.
Among the attendees were esteemed delegates, including officials from the Ministry of Health, esteemed academicians from universities, key industry leaders, scientific experts, and dedicated medical practitioners. This convergence facilitated insightful discussions and collaborations aimed at advancing ethical practices and professional standards in regenerative medicine and immunotherapy across the Asia Pacific region.
Past Events